p53 Protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival

Clinical Otolaryngology and Allied Sciences

Volumn 23, Issue 1, 1998, Pages 57-62

  Rowley, H ^a   Roland, N J ^a   Helliwell, T R ^a   Caslin, A ^a   Kinsella, A R ^a   Jones, A S ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cancer; Hypopharynx; Larynx; p53; SCCHN; Survival

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DATABASES, FACTUAL; ENGLAND; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031927391     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.1998.00087.x     Document Type: Article

References (32)

1. HOLLSTEIN M., RICE K., GREENBLATT M.S. et al. (1994) Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acids Res. 22 (17), 3551-3555
2. GREENBLATT M.S., BENNETT W.P., HOLLSTEIN M. & HARRIS C.C. (1994) Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878
3. BARTEK J., BARKOVA J., JOJTESEK B. et al. (1990) Patterns of expression of the p53 tumour supressor in human breast tissues in situ and in vitro. In. J. Cancer 46, 839-844
4. DAVIDOFF A.M., KERNS B.J., IGLEHART J.D. & MARKS, J. (1991) Maintenance of p53 alterations throughout breast cancer progression. Cancer Res. 61, 2605-2610
5. FIELD J.K., SPANDIDOS D.A., MALLIRI A. et al. (1991) Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. B. J. Cancer 64, 573-577
6. SOMERS K.D., MERRICK M.A., LOPEZ M.E. et al. (1992) Frequent p53 mutations in head and neck cancer. Cancer Res. 52, 5997-6000
7. NYLANDER K., NILSSON P., MEHLE C. & ROOS G. (1995) p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Br. J. Cancer 71, 826-830
8. FIELD J.K., ZOUMPOURLIS V., SPANDIDOS D.A. & JONES A.S. (1994) p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol. Cancer Detection Prevention 18 (3), 197-208
9. SNOW G.G. (1990) Head and neck carcinomas. Cur. Opinions Oncol. 2, 537-589
10. MAESTRO R., DOLCETTI R., GASPAROTTO D. et al. (1992) High frequency of p53 gene alterations associated with protein over-expression in human squamous cell carcinoma of the larynx. Oncogene 7, 1159-1165
11. DOLCETTI R., DOGLIONI C., MAESTRO R. et al. (1992) p53 over-expression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int. J. Cancer 52, 178-182
12. ANWAR K., NAKAKUKI K., IMAI H., NAIKI H. & INUZUKA M. (1993) Over-expression of p53 protein in human laryngeal carcinoma. Int. J. Cancer 53 (6), 952-956
13. SALAM M.A., CROCKER J. & MORRIS A. (1995) Overexpression of tumour suppressor gene p53 in laryngeal squamous cell carcinomas and its prognostic significance. Clin. Otolaryngol. 20 (1), 49-52
14. NADAL A., CAMPO E., PINTO J. et al. (1995) p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of correlation with prognostic factors. J. Pathol. 175 (2) 181-188
15. FRANK J.L., BUR M.E., GARB J.L. et al. (1994) p53 tumour suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 73 (1), 181-186
16. OTSU M., HAYASHI Y., AMATSU M. & ITOH H. (1994) Immunohistochemical study of p53, egf, egf-receptor, v-ert B and ras p21 in squamous cell carcinoma of the hypopharynx. Kobe J. Med. Sci. 40 (5-6), 139-153
17. SAS Institute Inc. (1988) SAS STAT Users Guide, release 6.03 edition. SAS Institute Inc. Cary, North Carolina, pp. 1-1028
18. ARMITAGE P. & BERRY G., eds. (1987) Survival analysis. In: Statistical Methods In Medical Research, 2nd edn, pp 421-439. Blackwell Scientific Publications, Oxford
19. PETO R., PIKE M.A., ARMITAGE P. et al. (1977) Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br. J. Cancer 35, 1-39
20. MACHIN D. & GARDNER M.J., (1989) Calculating confidence intervals for survival time analysis. In Gardner M.J. and Altman D.G., Eds. Statistics With Confidence, pp. 67-70. British Medical Journal (Publishing), London
21. BOAG G., LEE C. S., CHARALAMBOUS D. & RODE J. (1993) p53 expression in laryngeal carcinoma. Pathol. 25 (4), 394-397
22. SODER A., HOPMAN A.H.N. & RAMAEKERS F.C.S. (1995) Distinct non-random patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res. 55, 5030-5037
23. GOSNEY J.R., GOSNEY M.A., BUTT S.A. & FIELD J.K. (1993) Over-expression of p53 protein and cigarette smoking in bronchial carcinoma. Int. J. Ocol. 2, 1071-1074
24. O'CONNOR P.M., JACKSON J., JONDLE D. et al. (1993) Role of the p53 tumour suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53, 4776-4780
25. BRACHMAN D.G., GRAVES D., BOKES E. et al (1992) Occurrence of p53 deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 52, 4832-4836
26. MCILWRATH A.J., VASEY P.A., ROSS G.M. & BROWN P. (1994) Cell cycle arrests and radiosensitivity of human tumour cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res. 54 (14), 3718-3722
27. VOGELSTEIN B. & KINZLER K.W. (1994) Tumour suppressor genes. X-rays strike p53 again. Nature 370, 220-223
28. BRISTOW R.G., JANG A., PEACOCK J. et al. (1994) Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and or activated H-ras. Oncogene 9 (6), 1527-1536
29. WATTS S.L., BREWER E.E. & FRY T.L. (1991) Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg. Oral Med. Oral Pathol. 71, 701-707
30. WERNESS B.A., LEVINE A.J. & HOWLEY P.M. (1990) The E6 proteins encoded by human papillomavirus types 16 and 18 can complex p53 in vitro. Science 248, 76-79
31. DEMERS G.W., FOSTER S.A., HALBERT C.L. & GALLOWAY D.A. (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. (USA) 91 (10), 4382-4386
32. BRENNAN J.A., BOYLE J.O., KOCH W.M. et al (1995) Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. New Eng. J. Med. 332, 712-717